KIDNEY-FUNCTION AND DRUG-ACTION

被引：12

作者：

REIDENBERG, MM

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1985年 / 313卷 / 13期

关键词：

D O I：

10.1056/NEJM198509263131309

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：816 / 818

页数：3

共 10 条

[1]

BECKETT AH, 1965, LANCET, V1, P303

[2] DRUG PRESCRIBING IN RENAL-FAILURE - DOSING GUIDELINES FOR ADULTS [J].

BENNETT, WM ;

ARONOFF, GR ;

MORRISON, G ;

GOLPER, TA ;

PULLIAM, J ;

WOLFSON, M ;

SINGER, I .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1983, 3 (03) :155-193

[3] THE EFFECT OF DIETARY-PROTEIN ON THE CLEARANCE OF ALLOPURINOL AND OXYPURINOL [J].

BERLINGER, WG ;

PARK, GD ;

SPECTOR, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) :771-776

[4] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[5]

DETTLI L, 1976, Clinical Pharmacokinetics, V1, P126, DOI 10.2165/00003088-197601020-00004

[6]

DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P63

[7] PHARMACOLOGICALLY ACTIVE DRUG METABOLITES - THERAPEUTIC AND TOXIC ACTIVITIES, PLASMA AND URINE DATA IN MAN, ACCUMULATION IN RENAL-FAILURE [J].

DRAYER, DE .

CLINICAL PHARMACOKINETICS, 1976, 1 (06) :426-443

[8] SEVERE ALLOPURINOL TOXICITY - DESCRIPTION AND GUIDELINES FOR PREVENTION IN PATIENTS WITH RENAL-INSUFFICIENCY [J].

HANDE, KR ;

NOONE, RM ;

STONE, WJ .

AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) :47-56

[9] CENTRAL NERVOUS-SYSTEM EXCITATORY EFFECTS OF MEPERIDINE IN CANCER-PATIENTS [J].

KAIKO, RF ;

FOLEY, KM ;

GRABINSKI, PY ;

HEIDRICH, G ;

ROGERS, AG ;

INTURRISI, CE ;

REIDENBERG, MM .

ANNALS OF NEUROLOGY, 1983, 13 (02) :180-185

[10] ACCUMULATION OF NORMEPERIDINE, AN ACTIVE METABOLITE OF MEPERIDINE, IN PATIENTS WITH RENAL-FAILURE OR CANCER [J].

SZETO, HH ;

INTURRISI, CE ;

HOUDE, R ;

SAAL, S ;

CHEIGH, J ;

REIDENBERG, MM .

ANNALS OF INTERNAL MEDICINE, 1977, 86 (06) :738-741

← 1 →